The global vascular access devices market is expected to grow at a compound annual growth rate (CAGR) of 5.83% between 2024 and 2031, rising from USD 3.63 billion in 2023 to USD 5.71 billion by 2031. This growth is primarily driven by the increasing prevalence of chronic illnesses, a rise in hospital admissions, and ongoing improvements in global healthcare infrastructure.
Vascular access devices are medical tools used to deliver medications, fluids, nutrients, and blood directly into the bloodstream. These include devices such as peripherally inserted central catheters (PICCs), central venous catheters (CVCs), implantable ports, and peripheral intravenous catheters (PIVCs). Advances in healthcare and medical device technologies have led to significant improvements in the design, materials, and integration of imaging technologies in these devices. Enhanced flexibility, better biocompatibility, and the use of innovative materials have all contributed to better patient outcomes. Demand for these devices is increasing due to the surge in lifestyle-related diseases, a preference for minimally invasive procedures, and continual product innovation.
Example: In May 2024, Teleflex Inc. launched the Arrow EZ-IO Intraosseous Access Procedure Tray, which includes the first FDA-approved battery-powered driver suitable for sterile environments. This innovation aims to simplify vascular access in emergency settings.
However, concerns like infection risks and sepsis from long-term catheter use could pose barriers to market expansion.
Click – https://www.marketsandata.com/industry-reports/vascular-access-devices-market
Chronic Disease Surge to Drive Market Growth
The increasing incidence of chronic diseases such as cancer, cardiovascular, and urological disorders is one of the primary factors propelling the demand for vascular access devices. These conditions often require long-term treatments like dialysis and chemotherapy, which necessitate dependable vascular access. The aging global population further amplifies this demand, as older adults are more prone to such illnesses.
Example: According to the National Institutes of Health (NIH), the number of adults aged 50+ with at least one chronic condition will nearly double—from 71.5 million in 2020 to 142.6 million by 2050. The World Health Organization (WHO) predicts that by 2050, the global population aged 60+ will reach 2.1 billion.
Technological Advancements in Device Design
Standard vascular access options include central venous catheters (CVCs), arteriovenous fistulas (AVFs), and arteriovenous grafts (AVGs). Innovations in design—such as better catheter tips and advanced coatings—are enhancing performance by improving blood flow and reducing clotting and infection risks. AVFs, in particular, are gaining preference due to their reliability and lower complication rates.
Example: In September 2023, Laminate Medical Technologies received FDA clearance for its VasQ External Vascular Support device, which helps form AVFs for dialysis. Clinical trials showed that 80% of patients using VasQ were able to stop using central catheters within a year, thereby lowering infection risks.
Drug Administration as the Leading Application
The largest share of the vascular access devices market is attributed to drug delivery applications. These devices provide reliable long-term access for administering treatments such as chemotherapy, making them invaluable for patients requiring ongoing IV therapy. They help prevent complications like infections or vein damage from repeated needle use.
Example: A study published in the British Medical Journal in July 2024 confirmed that vascular access devices, when paired with proper safety measures, significantly reduce infection risks in hospitalized patients.
Regional Insights – North America Leads the Market
North America holds the dominant share of the global market, thanks to its advanced healthcare systems, rising chronic disease rates, and strong regulatory support. Technological innovations and demographic shifts—like an aging population—further drive demand in the region.
Example: The 2023 U.S. Renal Data System report indicated that over 85% of patients initiating hemodialysis used a catheter, with three-quarters lacking permanent access—up from 65% in 2018—highlighting increased device usage in the U.S.
Future Outlook (2024 – 2031)
The future of vascular access devices is set to be shaped by cutting-edge developments such as wearable tech, remote monitoring of AV flow, image-guided systems, and 3D-printed devices. Innovations like Abbott’s Ultreon 1.0, launched in October 2023, use near-infrared light to provide high-resolution imaging from inside blood vessels, enhancing precision in complex procedures. Additionally, FDA approvals of devices like WavelinQ and Ellipsys for minimally invasive AVF creation suggest a growing trend toward advanced endovascular techniques.
Report Scope
The report titled “Vascular Access Devices Market Assessment, Opportunities and Forecast, 2017–2031F”, by Markets and Data, offers a detailed evaluation of global market trends, dynamics, and key challenges. It provides quantitative and qualitative insights on market size, segment performance, future outlook, and profiles of leading companies, including their market positioning and business strategies.
Latest reports-
https://www.marketsandata.com/industry-reports/united-states-golf-shoes-market
https://www.marketsandata.com/industry-reports/aircraft-component-market
Comments